Back to Market Feed

MEPROBAMATE 400 MG TABLET

$5.7486per EA

DEA Schedule CIV

Strength

400 mg/1

Manufacturer

Alembic Pharmaceuticals Inc.

NDC

62332002031

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

Approval Type

Generic (ANDA)

FDA Application

On Market Since

3/31/2016

Price History

1W

0.0%

1M

+0.3%

3M

-3.1%

6M

-5.0%

1Y

+3.2%

3Y

+13.3%

5Y

+18.5%

All

+89.1%

Generic Alternatives

1 alternative • Same active ingredient

MEPROBAMATE 400 MG TABLET

69097097507•Cipla USA Inc.

Related Drugs

Same classification

No related drugs found.